welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Sarepta Announces Clinical Hold Lifted for its Duchenne Muscular Dystrophy Micro-dystrophin Gene Therapy Program
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, announced today that the Food and Drug Administration (FDA) has lifted the clinical hold for the Company’s Duchenne muscular dystrophy (DMD) micro-dystrophin gene therapy program. Sarepta previously announced on July 25, 2018, that the FDA placed the program on clinical hold due to the presence of trace amounts of DNA fragment in research-grade third-party supplied plasmid in a manufacturing lot. In response, and in collaboration with Nationwide Children’s Hospital, an action plan was developed and submitted to the FDA, including an audit of the plasmid supplier and a commitment to use GMP-s plasmid for all future production lots.
rareRelated
-
A Device for Rapid, Painless, Bedside Muscle Evaluation of ChildrenThe purpose of this protocol is to perfo...
-
Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)The main objective of this study is to e...
-
Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapiesOnce just a theory, gene therapies are n...
-
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201Wave Life Sciences Ltd., a biotechnology...
-
Modelling Duchenne Muscular Dystrophy in MYOD1-Converted Urine-Derived Cells Treated With 3-Deazaneplanocin A Hydroc...Duchenne muscular dystrophy (DMD) is a s...
-
Duchenne Muscular Dystrophy Clinical TrialThe primary objective of this investigat...
-
Development of Novel Micro-dystrophins with Enhanced FunctionalityGene therapies using adeno-associated vi...
-
Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular DystrophyDuchenne muscular dystrophy (DMD) is an ...
